Exelixis, Inc. (EXEL) trades at a trailing P/E of 15.3, forward P/E of 15.6. Trailing earnings yield is 6.54%, forward earnings yield 6.43%. PEG 0.26 (Peter Lynch undervalued ≤1.0). Graham Number is $22.72.
Criteria proven by this page:
Overall SharesGrow Score: 83/100 with 6/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -53.2 | 0.81 | 41.82 | 19.51 | - |
| 2017 | 57.9 | -0.20 | 31.32 | 19.72 | - |
| 2018 | 8.5 | 0.02 | 4.55 | 6.86 | - |
| 2019 | 16.6 | -0.31 | 3.16 | 5.51 | - |
| 2020 | 55.3 | -0.84 | 3.29 | 6.27 | - |
| 2021 | 24.9 | 0.24 | 2.60 | 4.01 | - |
| 2022 | 28.3 | -1.29 | 2.07 | 3.20 | - |
| 2023 | 36.7 | 2.62 | 3.37 | 4.17 | - |
| 2025 | 18.9 | 0.11 | 4.39 | 4.54 | - |
| 2026 | 15.1 | 0.25 | 5.48 | 5.10 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-0.28 | $191.45M | $-70.22M | -36.7% |
| 2017 | $0.49 | $452.48M | $154.23M | 34.1% |
| 2018 | $2.21 | $853.83M | $690.07M | 80.8% |
| 2019 | $1.02 | $967.78M | $321.01M | 33.2% |
| 2020 | $0.35 | $987.54M | $111.78M | 11.3% |
| 2021 | $0.72 | $1.43B | $231.06M | 16.1% |
| 2022 | $0.56 | $1.61B | $182.28M | 11.3% |
| 2023 | $0.65 | $1.83B | $207.77M | 11.4% |
| 2024 | $1.76 | $2.17B | $521.27M | 24% |
| 2025 | $2.78 | $2.32B | $782.57M | 33.7% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $2.95 | $2.77 – $3.09 | $2.32B | $2.15B – $2.48B | 13 |
| 2027 | $3.31 | $3.13 – $3.56 | $2.58B | $2.51B – $2.66B | 12 |
| 2028 | $3.92 | $3.39 – $4.46 | $2.95B | $2.83B – $3.06B | 11 |
| 2029 | $4.77 | $2.26 – $7.45 | $3.26B | $3.25B – $3.26B | 12 |
| 2030 | $5.57 | $5.05 – $6.07 | $3.42B | $3.17B – $3.66B | 5 |
